NTI to receive in-vitro results shortly – could its unique cannabis strain be a game changer?

ASX cannabis stocks are gaining momentum, stimulated by significant developments in the global regulatory environments in recent months. On the cusp of a potential rerate is $29M capped Neurotech International…

Continue Reading NTI to receive in-vitro results shortly – could its unique cannabis strain be a game changer?

Creso Pharma ready to take on recreational cannabis market as purchase orders mount up

Last week, Creso Pharma Limited’s (ASX:CPH; FRA: 1X8) wholly-owned Canadian cannabis cultivation subsidiary, Mernova Medicinal Inc. received three purchase orders with a combined value of C$275,023 (A$288,159). These new purchase…

Continue Reading Creso Pharma ready to take on recreational cannabis market as purchase orders mount up